<?xml version="1.0" encoding="UTF-8"?>
<p>Throughout the study period, all clients diagnosed with TB were eligible for TB treatment [
 <xref rid="pone.0195208.ref035" ref-type="bibr">35</xref>], but not all clients were eligible for ART. At the beginning of the study period (January 2008) all HIV-positive individuals who had a CD4 count of ≤200 cells/mm
 <sup>3</sup> were offered ART at the public health facility [
 <xref rid="pone.0195208.ref036" ref-type="bibr">36</xref>]. In 2010, the policy changed and ART was offered to HIV-positive individuals with CD4 ≤350 cells/mm
 <sup>3</sup> [
 <xref rid="pone.0195208.ref037" ref-type="bibr">37</xref>] and to all individuals co-infected with TB, irrespective of CD4 count [
 <xref rid="pone.0195208.ref037" ref-type="bibr">37</xref>]. The study ended prior to the current guidelines (in which all HIV positive individuals are offered ART regardless CD4 count) [
 <xref rid="pone.0195208.ref038" ref-type="bibr">38</xref>].
</p>
